BusinessClinical investigator associated with study at Alembic’s bioequivalence unit gets U.S. FDA warning letter· 7/13/2026, 5:23:53 PM· 3 min readRead original story →Share:TwitterFacebookWhatsAppLinkedInCopy linkRelated storiesbusinessParamount and Warner Bros sued to block $110bn mega mergerbusinessHCL posts 20% growth in Q1 net profit at ₹4,624 cr.businessAditya Birla Group to acquire Sprng Energy from Shell in ₹17,200 crore dealbusinessOpenAI launches ChatGPT Work, introduces GPT-5.6 model family
